Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 02:20:11 UTC |
---|
Update Date | 2021-09-26 22:59:21 UTC |
---|
HMDB ID | HMDB0248852 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Balapiravir |
---|
Description | [2-azido-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)-3,4-bis[(2-methylpropanoyl)oxy]oxolan-2-yl]methyl 2-methylpropanoate belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Based on a literature review very few articles have been published on [2-azido-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)-3,4-bis[(2-methylpropanoyl)oxy]oxolan-2-yl]methyl 2-methylpropanoate. This compound has been identified in human blood as reported by (PMID: 31557052 ). Balapiravir is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Balapiravir is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(C)C(=O)OCC1(OC(C(OC(=O)C(C)C)C1OC(=O)C(C)C)N1C=CC(N)=NC1=O)N=[N+]=[N-] InChI=1S/C21H30N6O8/c1-10(2)17(28)32-9-21(25-26-23)15(34-19(30)12(5)6)14(33-18(29)11(3)4)16(35-21)27-8-7-13(22)24-20(27)31/h7-8,10-12,14-16H,9H2,1-6H3,(H2,22,24,31) |
---|
Synonyms | Value | Source |
---|
[2-Azido-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)-3,4-bis[(2-methylpropanoyl)oxy]oxolan-2-yl]methyl 2-methylpropanoic acid | Generator |
|
---|
Chemical Formula | C21H30N6O8 |
---|
Average Molecular Weight | 494.505 |
---|
Monoisotopic Molecular Weight | 494.21251195 |
---|
IUPAC Name | [5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-2-azido-3,4-bis[(2-methylpropanoyl)oxy]oxolan-2-yl]methyl 2-methylpropanoate |
---|
Traditional Name | [5-(4-amino-2-oxopyrimidin-1-yl)-2-azido-3,4-bis[(2-methylpropanoyl)oxy]oxolan-2-yl]methyl 2-methylpropanoate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)C(=O)OCC1(OC(C(OC(=O)C(C)C)C1OC(=O)C(C)C)N1C=CC(N)=NC1=O)N=[N+]=[N-] |
---|
InChI Identifier | InChI=1S/C21H30N6O8/c1-10(2)17(28)32-9-21(25-26-23)15(34-19(30)12(5)6)14(33-18(29)11(3)4)16(35-21)27-8-7-13(22)24-20(27)31/h7-8,10-12,14-16H,9H2,1-6H3,(H2,22,24,31) |
---|
InChI Key | VKXWOLCNTHXCLF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | Glycosylamines |
---|
Alternative Parents | |
---|
Substituents | - N-glycosyl compound
- Tricarboxylic acid or derivatives
- Aminopyrimidine
- Pyrimidone
- Hydropyrimidine
- Imidolactam
- Monosaccharide
- Pyrimidine
- Primary aromatic amine
- Heteroaromatic compound
- Oxolane
- Amino acid or derivatives
- Azo compound
- Azo imide
- Carboxylic acid ester
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organopnictogen compound
- Organic nitrogen compound
- Amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organic salt
- Organonitrogen compound
- Organic zwitterion
- Primary amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Balapiravir,1TMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N[Si](C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 3316.8 | Semi standard non polar | 33892256 | Balapiravir,1TMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N[Si](C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 3121.5 | Standard non polar | 33892256 | Balapiravir,1TMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N[Si](C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 5273.5 | Standard polar | 33892256 | Balapiravir,2TMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 3208.9 | Semi standard non polar | 33892256 | Balapiravir,2TMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 3215.8 | Standard non polar | 33892256 | Balapiravir,2TMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N([Si](C)(C)C)[Si](C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 4869.3 | Standard polar | 33892256 | Balapiravir,1TBDMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N[Si](C)(C)C(C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 3490.6 | Semi standard non polar | 33892256 | Balapiravir,1TBDMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N[Si](C)(C)C(C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 3292.5 | Standard non polar | 33892256 | Balapiravir,1TBDMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N[Si](C)(C)C(C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 5240.7 | Standard polar | 33892256 | Balapiravir,2TBDMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 3590.8 | Semi standard non polar | 33892256 | Balapiravir,2TBDMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 3555.8 | Standard non polar | 33892256 | Balapiravir,2TBDMS,isomer #1 | CC(C)C(=O)OCC1(N=[N+]=[N-])OC(N2C=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C | 4841.8 | Standard polar | 33892256 |
|
---|